newsfilter
← Latest News
PR Newswire·

Oramed Pharmaceuticals Inc. Announces the Buy-Back of its Common Stock

Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (the "Company") (www.oramed.com), a clinical-stage pharmaceutical company focused on the...